argenx SE | ARGX - Net Income

Stock Price
693.20
Daily Change
-1.00 -0.14%
Monthly
-2.45%
Yearly
37.43%
Q2 Forecast
678.23

argenx SE reported $366M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
AstraZeneca USD 3.08B 754M Mar/2026
Genmab DKK 31M 370M Dec/2025
GlaxoSmithKline GBP 1.74B 1.1B Mar/2026
GRIFOLS EUR 73M 25.25M Mar/2026
Hikma Pharmaceutical USD 164M 45M Dec/2025
Lakefront Biotherapeutics EUR 14.49M 767.65M Mar/2026
Qiagen NV USD 107.83M 22.21M Dec/2025
UCB EUR 1.08B 608M Dec/2025